• Navigation überspringen
  • Zur Navigation
  • Zum Seitenende
Organisationsmenü öffnen Organisationsmenü schließen
Institute of Medical Biotechnology
  • FAUZur zentralen FAU Website
  1. Friedrich-Alexander-Universität
  2. Technische Fakultät
  3. Department Chemie- und Bioingenieurwesen
  • Campo
  • UnivIS
  • Stellenangebote
  • Lageplan
  • Hilfe im Notfall
  1. Friedrich-Alexander-Universität
  2. Technische Fakultät
  3. Department Chemie- und Bioingenieurwesen

Institute of Medical Biotechnology

Menu Menu schließen
  • About Us
    • Staff
    • Open Positions
    • Graduation
    • Our Labs
    • Contact
    Portal About Us
  • Research
    • Research Groups
    • Collaborations
    • Publications
    Portal Research
  • Teaching
    • Lectures
    • Scientific Talks
    Portal Teaching
  1. Startseite
  2. Research
  3. Research Groups
  4. Malaria Biotechnology
  5. Metabolic enzymes as drug targets

Metabolic enzymes as drug targets

Bereichsnavigation: Research
  • Research Groups
    • Muscle Opto-Biomechatronics
      • The MyoRobot
      • The MechaMorph
      • The IsoStretcher
      • Virtual Laboratory
    • Malaria Biotechnology
      • RG Protein Engineering
      • Metabolic enzymes as drug targets
      • Identification of novel antimalarial compounds
      • Mitosis as drug target
      • Identification of transporters of the MGC-basic proteins
      • Characterization of drug-resistance transporters of the digestive vacuole
      • Malaria vaccine directed against blood stages
    • Tissue Engineering
      • Bone Tissue Engineering
      • Research Topic 2 (TE)
      • Research Topic 3 (TE)
    • Optical Technologies in Life Sciences
      • Label-free Multiphoton Imaging
      • Multiphoton Endomicroscopy for Life Science and Medicine
      • Raman Spectroscopy of Biological Tissue
      • PiezoGRIN: Multiphoton Imaging under high Pressures
    • High-throughput Biology & Robophotonics
      • High-throughput Biology & Functional Neurogenomics
      • Robophotonics & Rapid Prototyping
  • Collaborations
  • Publications

Metabolic enzymes as drug targets

Group Leader

Barbara Kappes

Prof. Dr. Barbara Kappes

Group Leader

Medical Biotechnology
Malaria Biotechnology

Raum: Room 01.020
Paul-Gordan-Str. 3
91052 Erlangen
Germany
  • Telefon: +49913185-23299
  • E-Mail: barbara.kappes@fau.de
  • Webseite: https://www.mbt.tf.fau.de/
Nina Simon

Dr. Nina Simon

Group Leader

Medical Biotechnology
Malaria Biotechnology

Raum: Room 00.115
Ulrich-Schalk-Str. 3
91056 Erlangen
Germany
  • Telefon: +49913185-69657
  • E-Mail: nina.simon@fau.de

The malaria parasite synthesizes vitamin B6 de novo via the PLP (pyridoxal -5-phosphate) synthase enzymatic complex consisting of PfPdx1 and PfPdx2 proteins (Gengenbacher et al., 2006; Guédez et al., 2012; Pdx1-Pdx2 complex illustration by Strohmeier et al., 2006). In the malaria parasite, biosynthesis of PLP is largely performed by PfPdx1, while humans do not own this enzyme and have to take up vitamin B6 by their diet. Our goal is to rule out the impact of PfPdx1 on metabolic regulation of malaria blood stages.

 

Friedrich-Alexander-Universität
Erlangen-Nürnberg

Schlossplatz 4
91054 Erlangen
  • Imprint
  • Privacy
  • Accessibility
Nach oben